Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

The Ewing sarcoma protein regulates DNA damage-induced alternative splicing.

Paronetto MP, Miñana B, Valcárcel J.

Mol Cell. 2011 Aug 5;43(3):353-68. doi: 10.1016/j.molcel.2011.05.035.

2.

Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.

Fidaleo M, Svetoni F, Volpe E, Miñana B, Caporossi D, Paronetto MP.

Oncotarget. 2015 Oct 13;6(31):31740-57. doi: 10.18632/oncotarget.5033.

3.
4.

Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.

Watanabe G, Nishimori H, Irifune H, Sasaki Y, Ishida S, Zembutsu H, Tanaka T, Kawaguchi S, Wada T, Hata J, Kusakabe M, Yoshida K, Nakamura Y, Tokino T.

Genes Chromosomes Cancer. 2003 Mar;36(3):224-32.

PMID:
12557222
5.

Dynamic subcellular localization of the Ewing sarcoma proto-oncoprotein and its association with and stabilization of microtubules.

Leemann-Zakaryan RP, Pahlich S, Sedda MJ, Quero L, Grossenbacher D, Gehring H.

J Mol Biol. 2009 Feb 13;386(1):1-13. doi: 10.1016/j.jmb.2008.12.039. Epub 2008 Dec 24.

PMID:
19133275
6.

Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.

Chansky HA, Hu M, Hickstein DD, Yang L.

Cancer Res. 2001 May 1;61(9):3586-90.

7.

Accumulation of pre-let-7g and downregulation of mature let-7g with the depletion of EWS.

Sohn EJ, Park J, Kang SI, Wu YP.

Biochem Biophys Res Commun. 2012 Sep 14;426(1):89-93. doi: 10.1016/j.bbrc.2012.08.041. Epub 2012 Aug 14.

PMID:
22910415
8.

Stimulation of Oct-4 activity by Ewing's sarcoma protein.

Lee J, Rhee BK, Bae GY, Han YM, Kim J.

Stem Cells. 2005 Jun-Jul;23(6):738-51.

9.

Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.

Carrillo J, García-Aragoncillo E, Azorín D, Agra N, Sastre A, González-Mediero I, García-Miguel P, Pestaña A, Gallego S, Segura D, Alonso J.

Clin Cancer Res. 2007 Apr 15;13(8):2429-40.

10.
11.

An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins.

Guipaud O, Guillonneau F, Labas V, Praseuth D, Rossier J, Lopez B, Bertrand P.

Proteomics. 2006 Nov;6(22):5962-72.

PMID:
17106916
12.

Aberrant laminin beta3 isoforms downstream of EWS-ETS fusion genes in Ewing family tumors.

Irifune H, Nishimori H, Watanabe G, Yoshida K, Ikeda T, Matsui C, Morohashi M, Kawaguchi S, Nagoya S, Wada T, Yamashita T, Nakamura Y, Tokino T.

Cancer Biol Ther. 2005 Apr;4(4):449-55. Epub 2005 Apr 21.

PMID:
15846078
13.

Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.

Sanchez G, Bittencourt D, Laud K, Barbier J, Delattre O, Auboeuf D, Dutertre M.

Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6004-9. doi: 10.1073/pnas.0710748105. Epub 2008 Apr 14.

14.

TLS, EWS and TAF15: a model for transcriptional integration of gene expression.

Law WJ, Cann KL, Hicks GG.

Brief Funct Genomic Proteomic. 2006 Mar;5(1):8-14. Epub 2006 Feb 23. Review.

PMID:
16769671
16.
17.

The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.

Nishimori H, Sasaki Y, Yoshida K, Irifune H, Zembutsu H, Tanaka T, Aoyama T, Hosaka T, Kawaguchi S, Wada T, Hata J, Toguchida J, Nakamura Y, Tokino T.

Oncogene. 2002 Nov 28;21(54):8302-9.

18.

The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.

Navarro D, Agra N, Pestaña A, Alonso J, González-Sancho JM.

Carcinogenesis. 2010 Mar;31(3):394-401. doi: 10.1093/carcin/bgp317. Epub 2009 Dec 17.

PMID:
20019092
19.

Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.

Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL Jr.

Cancer Res. 2005 Oct 1;65(19):8698-705.

Supplemental Content

Support Center